Kevin Ray received his PhD in Analytical Chemistry from Texas A&M University (TX, US). He joined MilliporeSigma (MA, US), formerly Sigma-Aldrich (MO, US), in 1994 and is currently Head of Analytical Research and Development leading a team responsible for providing advanced analytical support to product development groups in the Life Science Business, and serving as a corporate center of excellence for mass spectrometry.
In this podcast, Kevin discusses the techniques and technologies utilized in drug metabolism studies for biotherapeutics, and what he believes the future holds for the field.
Learn more about Kevin’s latest development, a PK Kit for mAbs, here.
The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada.